[EN] NON-RIBOSE CONTAINING INHIBITORS OF HISTONE METHYLTRANSFERASE DOT1L FOR CANCER TREATMENT<br/>[FR] INHIBITEURS D'HISTONE MÉTHYLTRANSFÉRASE DOT1L NE CONTENANT PAS DE RIBOSE DESTINÉS AU TRAITEMENT DU CANCER
申请人:BAYLOR COLLEGE MEDICINE
公开号:WO2015013256A1
公开(公告)日:2015-01-29
A compound of Formula I, a pharmaceutically acceptable salt thereof, a prodrug thereof, or combinations thereof: wherein R1 is H, methyl, or benzyl: R2 is 2-cyanoethyl, 2-methoxycarbonylethyl, or 2-iodoethyl; X is N or S; wherein if X = S, R2 = 0; Y is C3 or C4; Z1 is O, S, N, or CH2; and Z2 is N or CR4, wherein R4 is a halogen, alkyl, aryl or a 5- or 6-membered heterocycle; and wherein said compound is selective for DOT1L Methyl Transferase.
一种符合以下公式I的化合物,其药学上可接受的盐,其前体药物,或其组合物:其中R1为H,甲基或苄基;R2为2-氰乙基,2-甲氧羰基乙基或2-碘乙基;X为N或S;其中如果X = S,则R2 = 0;Y为C3或C4;Z1为O,S,N或CH2;Z2为N或CR4,其中R4为卤素,烷基,芳基或5-或6-成员杂环;所述化合物对DOT1L甲基转移酶具有选择性。